503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.59%
Some net income increase while ORCL is negative at -39.06%. John Neff would see a short-term edge over the struggling competitor.
-3.95%
Negative yoy D&A while ORCL is 0.66%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-17458.82%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
8.34%
Less SBC growth vs. ORCL's 23.30%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
205.26%
Less working capital growth vs. ORCL's 1096.43%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
190.35%
AR growth well above ORCL's 212.70%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-100.26%
Negative yoy inventory while ORCL is 103.33%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-129.13%
Both negative yoy AP, with ORCL at -418.30%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-131.10%
Both reduce yoy usage, with ORCL at -19.06%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
12.50%
Lower 'other non-cash' growth vs. ORCL's 89.85%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
8.06%
Operating cash flow growth at 50-75% of ORCL's 11.34%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
9.95%
Some CapEx rise while ORCL is negative at -48.12%. John Neff would see competitor possibly building capacity while we hold back expansions.
-140.72%
Both yoy lines negative, with ORCL at -316.67%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
30.71%
Purchases well above ORCL's 31.55%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
37.46%
We have some liquidation growth while ORCL is negative at -0.29%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-196.08%
We reduce yoy other investing while ORCL is 110.40%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
70.05%
Investing outflow well above ORCL's 80.03%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
36.00%
We slightly raise equity while ORCL is negative at -83.01%. John Neff sees competitor possibly preserving share count or buying back shares.
-7.06%
Both yoy lines negative, with ORCL at -9.57%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.